ZNF167 Inhibitors
ZNF167 inhibitors are a set of chemical entities that indirectly attenuate the functional activity of ZNF167 by influencing specific signaling pathways associated with its regulatory actions. PD 98059 and U0126 serve as MEK inhibitors, resulting in the suppression of the MAPK/ERK pathway, crucial for the downstream signaling that directly affects the regulatory functions of ZNF167. In parallel, PI3K inhibitors LY 294002 and Wortmannin contribute to the attenuation of AKT signaling, a pathway that is pertinent for maintaining the stability and nuclear functions of ZNF167. This leads to an indirect but significant reduction in ZNF167's activity within its nuclear domain. The influence of mTOR signaling on protein synthesis and cellular processes is mitigated by Rapamycin, which, by decreasing overall cellular activity, indirectly diminishes the functional participation of ZNF167 in these processes.
Furthermore, SB 203580 and SP600125, as specific inhibitors of p38 MAPK and JNK, respectively, alter the stress response and transcriptional regulation pathways in which ZNF167 is involved, leading to a potential decrease in its functional activity. Y-27632 impacts Rho-associated protein kinase (ROCK), affecting the cytoskeletal dynamics that could be essential for the regulation of ZNF167's nuclear localization and function. Trichostatin A, by inhibiting histone deacetylase, can affect chromatin remodeling and, consequently, the transcriptional regulation activities of ZNF167. Cyclosporin A and Chelerythrine, targeting calcineurin and PKC respectively, may disrupt downstream signaling processes that influence the functional role of ZNF167 in the immune response and other cellular pathways. Lastly, Curcumin's modulation of multiple signaling pathways, including the inhibition of NF-κB, a key transcriptional regulator, suggests a potential cascade of effects leading to the diminished regulatory capacity of ZNF167 in gene expression modulation, thus comprehensively covering the spectrum of indirect biochemical mechanisms through which ZNF167's activity can be inhibited.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a selective inhibitor of MEK, which prevents the activation of MAPK/ERK pathway. ZNF167, being regulated by this pathway, has its functional activity diminished due to the suppression of the downstream signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a phosphatidylinositol 3-kinase (PI3K) inhibitor. By inhibiting PI3K, it leads to the downregulation of AKT signaling, which is crucial for the stability and function of ZNF167 in the nucleus. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, which leads to decreased protein synthesis and cell proliferation. As a result, the biological processes in which ZNF167 is involved are indirectly inhibited through reduced cellular activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a specific inhibitor of p38 MAPK. By inhibiting p38 MAPK, it can interfere with stress response signaling pathways, indirectly leading to the diminished regulatory function of ZNF167. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which alters the JNK signaling pathway. As ZNF167 is involved in transcriptional regulation, inhibition of JNK can lead to decreased transcriptional activity impacting ZNF167 function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits the Rho-associated protein kinase (ROCK), which impacts cytoskeleton organization. This can affect the nuclear localization signals, which in turn may diminish the functional activity of ZNF167 in the nucleus. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible PI3K inhibitor. By suppressing PI3K activity, it indirectly affects the nuclear functions and stability of ZNF167 by altering signaling pathways that maintain nuclear integrity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. It alters the chromatin state, which can lead to changes in the transcriptional activity of genes, potentially diminishing the regulatory role of ZNF167 in gene expression. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is an immunosuppressant that inhibits calcineurin. By doing so, it disrupts T-cell signal transduction which could indirectly downregulate the functional activity of ZNF167 in immune response related pathways. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Chelerythrine is a selective inhibitor of protein kinase C (PKC). PKC is involved in various signaling pathways, and its inhibition can lead to decreased activity of ZNF167 if PKC indirectly regulates ZNF167 stability. | ||||||